Epigenetic Control of the Immune System in Health and Disease

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".

Deadline for manuscript submissions: closed (30 September 2021) | Viewed by 4630

Special Issue Editor


E-Mail Website
Guest Editor
1. Sección de Endocrinología y Nutrición, Hospital V. Álvarez Buylla, Calle Vistalegre, 2, 33611 Mieres, Asturias, Spain
2. Epigenética del Cáncer y Nanomedicina, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias, Avda. Hospital Universitario s/n, 33011 Oviedo, Spain
Interests: autoimmunity; T1D; cancer; epigenetics; aging
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The immune system is an intricated, combined functional cluster of structures, tissues, cells, and cell products with a mission that is to differentiate self from non-self. It allows it to protect the organism from potentially pathogenic agents or substances, but also it is important for them to recognize and respect own organs.

Epigenetic mechanisms are a key element for immune system to develop and enable an adequate gene expression pattern of their cells. Moreover, pathogenic factors (infections, tumoral transformed cells, toxic compounds) that this immune system can be exposed to, might be considered some kind of environmental pressure that also induces additional epigenetic changes to adapt to those novel elements and control them.

Health and disease in humans are not a black and white picture. During life, complex interactions between genetics, time (and aging), risk factors and deleterious exposures, system responses (adapted or not) and a little luck (or not) can be combined. All these are factors that are found to induce epigenetic changes of different cellular structures to adapt (included the immune system).

For this Special Issue, we are inviting manuscripts where epigenetic changes of immune system are described: ontogenic development of their cells, but also as part of immune response in infections or immunosurveillance, autoimmunity, inflammation activity or immune senescence. The interest that these mechanisms have is broad, such as being able to respond to pathophysiological mechanisms that are still little known, identify new therapeutic targets or even as diagnostic or susceptibility markers for the development of diseases.

Dr. Juan Luis Fernandez-Morera
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • immune system
  • autoimmunity
  • immunosurveillance
  • inflammation
  • immunosenescence
  • immunological tolerance

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

22 pages, 1590 KiB  
Review
An Epigenetic Insight into NLRP3 Inflammasome Activation in Inflammation-Related Processes
by Aroa Baragaño Raneros, Cristian Ruiz Bernet, Aida Bernardo Flórez and Beatriz Suarez-Alvarez
Biomedicines 2021, 9(11), 1614; https://0-doi-org.brum.beds.ac.uk/10.3390/biomedicines9111614 - 04 Nov 2021
Cited by 19 | Viewed by 4098
Abstract
Aberrant NLRP3 (NOD-, LRR-, and pyrin domain-containing protein 3) inflammasome activation in innate immune cells, triggered by diverse cellular danger signals, leads to the production of inflammatory cytokines (IL-1β and IL-18) and cell death by pyroptosis. These processes are involved in the pathogenesis [...] Read more.
Aberrant NLRP3 (NOD-, LRR-, and pyrin domain-containing protein 3) inflammasome activation in innate immune cells, triggered by diverse cellular danger signals, leads to the production of inflammatory cytokines (IL-1β and IL-18) and cell death by pyroptosis. These processes are involved in the pathogenesis of a wide range of diseases such as autoimmune, neurodegenerative, renal, metabolic, vascular diseases and cancer, and during physiological processes such as aging. Epigenetic dynamics mediated by changes in DNA methylation patterns, chromatin assembly and non-coding RNA expression are key regulators of the expression of inflammasome components and its further activation. Here, we review the role of the epigenome in the expression, assembly, and activation of the NLRP3 inflammasome, providing a critical overview of its involvement in the disease and discussing how targeting these mechanisms by epigenetic treatments could be a useful strategy for controlling NLRP3-related inflammatory diseases. Full article
(This article belongs to the Special Issue Epigenetic Control of the Immune System in Health and Disease)
Show Figures

Figure 1

Back to TopTop